4//SEC Filing
Yamashita Elizabeth A. 4
Accession 0001209191-17-067235
CIK 0001649989other
Filed
Dec 25, 7:00 PM ET
Accepted
Dec 26, 5:07 PM ET
Size
5.3 KB
Accession
0001209191-17-067235
Insider Transaction Report
Form 4
Yamashita Elizabeth A.
VP, Regulatory Affairs
Transactions
- Sale
Common Stock
2017-12-22$1.13/sh−16,170$18,272→ 64,648 total
Footnotes (2)
- [F1]Represents the number of shares required to be sold by the Reporting Person to cover the tax withholding obligation in connection with the settlement of vested restricted stock units ("RSUs"). This sale is mandated by the Issuer's election under its equity incentive plans to require the Reporting Person to fund this tax withholding obligation by completing a "sell to cover" transaction with a brokerage firm designated by the Issuer. This sale does not represent a discretionary trade by the Reporting Person.
- [F2]Includes 21,739 shares of the Issuer's common stock subject to RSUs that will vest on 4/7/2018, subject to continued service through such date.
Documents
Issuer
Oncobiologics, Inc.
CIK 0001649989
Entity typeother
Related Parties
1- filerCIK 0001663252
Filing Metadata
- Form type
- 4
- Filed
- Dec 25, 7:00 PM ET
- Accepted
- Dec 26, 5:07 PM ET
- Size
- 5.3 KB